Irinotecan Kabi 20 mg/ml concentrate for solution for infusion

Country: Բուլղարիա

language: բուլղարերեն

source: Изпълнителна агенция по лекарствата

active_ingredient:

Иринотекан

MAH:

Fresenius Kabi Oncology Plc.

ATC_code:

L01XX19

INN:

Irinotecan

dosage:

20 mg/ml concentrate for solution for infusion

leaflet_short:

Irinotecan Kabi, 20 mg/ml concentrate for solution for infusion - 2 ml x 1;2 ml x 5; 5 ml x 1; 5 ml x 5

authorization_date:

2013-12-18